- Research article
- Open Access
Clostridium perfringens strains from bovine enterotoxemia cases are not superior in in vitroproduction of alpha toxin, perfringolysin O and proteolytic enzymes
BMC Veterinary Research volume 10, Article number: 32 (2014)
Bovine enterotoxemia is a major cause of mortality in veal calves. Predominantly veal calves of beef cattle breeds are affected and losses due to enterotoxemia may account for up to 20% of total mortality. Clostridium perfringens type A is considered to be the causative agent. Recently, alpha toxin and perfringolysin O have been proposed to play an essential role in the development of disease. However, other potential virulence factors also may play a role in the pathogenesis of bovine enterotoxemia. The aim of this study was to evaluate whether strains originating from bovine enterotoxemia cases were superior in in vitro production of virulence factors (alpha toxin, perfringolysin O, mucinase, collagenase) that are potentially involved in enterotoxemia. To approach this, a collection of strains originating from enterotoxemia cases was compared to bovine strains isolated from healthy animals and to strains isolated from other animal species.
Strains originating from bovine enterotoxemia cases produced variable levels of alpha toxin and perfringolysin O that were not significantly different from levels produced by strains isolated from healthy calves and other animal species. All tested strains exhibited similar mucinolytic activity independent of the isolation source. A high variability in collagenase activity between strains could be observed, and no higher collagenase levels were produced in vitro by strains isolated from enterotoxemia cases.
Bovine enterotoxemia strains do not produce higher levels of alpha toxin, perfringolysin O, mucinase and collagenase, as compared to strains derived from healthy calves and other animal species in vitro.
Bovine enterotoxemia caused by Clostridium perfringens, is a sudden death syndrome with necro-hemorrhagic lesions in the small intestine, which mainly affects suckling calves and veal calves [1, 2]. In veal calves, predominantly beef cattle breeds are affected. The syndrome accounts for approximately 20% of the mortalities in these calves, compared to 4% in dairy and mixed breed veal calves [2, 3]. Clostridium perfringens is an anaerobic gram-positive spore-forming bacterium, which is a commensal of the gastrointestinal tract of both humans and animals, and is also ubiquitous in soil and sewage [2, 4, 5]. Strains of C. perfringens are classified into five toxinotypes (A-E) based on the presence of four major toxin genes (alpha, beta, iota and epsilon) . Mainly strains of type A are recovered from enterotoxemia cases but also from the intestine of healthy cattle and other warm-blooded animals as well as from the environment . C. perfringens type A has the ability to produce numerous extracellular toxins and enzymes, of which alpha toxin is the most toxic . Recently alpha toxin, a phospholipase C, and perfringolysin O, a pore forming cytolysin, have been proposed as essential factors for induction of enterotoxemia . In addition to these toxins, other potential virulence factors might have a role in the pathology of enterotoxemia. Possible virulence traits can be proteolytic factors that degrade the protective mucus layer and extracellular matrix components or intra-species inhibitory antibacterial substances that confer a selective advantage to the producing strain, as suggested for necrotic enteritis strains in broilers .
It is hitherto unclear whether the C. perfringens type A strains isolated from enterotoxemia cases are more virulent than other type A strains. In a calf intestinal loop model, it has been shown that C. perfringens strains isolated from healthy and enterotoxemic cattle as well as from other host species are all capable of inducing necro-hemorrhagic intestinal lesions .
The purpose of this study was to analyze the expression of virulence factors that are potentially involved in enterotoxemia. To approach this, the alpha toxin and perfringolysin O production, the mucinolytic and gelatinolytic activity as well as the intra-species inhibitory activity of a collection of strains originating from enterotoxemia cases was compared to bovine strains isolated from healthy animals and to strains isolated from other animal species.
Clostridium perfringensstrains from enterotoxemia cases are not superior alpha toxin and perfringolysin O producers
To determine whether alpha toxin and perfringolysin O levels differ between bovine enterotoxemia strains and strains from other sources, the culture supernatants of various type A strains were tested (Figure 1A). Lecithin breakdown was used as a measure of alpha toxin activity. The supernatants of the different strains showed high variability in alpha toxin activity, independent of their origin. In eight strains, the alpha toxin activity was below the detection limit of 15.6 10-3 U/ml (three strains originating from enterotoxemia cases and five strains from healthy calves). Perfringolysin O activity was determined by measuring the hemolysis of horse erythrocytes. Supernatants of strains originating from bovine enterotoxemia cases showed a high variability in hemolytic activity. The mean erythrocyte hydrolysis by strains from bovine enterotoxemia was not significantly different from other strains, independent of the origin (Figure 1B). For both alpha toxin and perfringolysin O, no significant differences between enterotoxemia strains and other C. perfringens strains could be observed.
Mucinolytic and gelatinolytic activity is not higher in Clostridium perfringensstrains from bovine enterotoxemia cases
The thickness of the mucin layer reflects an equilibrium between synthesis by the host and bacterial degradation by the intestinal microbiota. We tested the mucinolytic activity of C. perfringens strains from enterotoxemia cases and from other sources to evaluate whether enterotoxemia strains have higher potential to degrade the protective mucus layer. All strains exhibited similar mucinolytic activity (Figure 1C). To elucidate whether C. perfringens proteases might have the potential to contribute to the pathology of enterotoxemia, gelatinolytic activity was investigated as a measure for degrading extracellular matrix components within the gut. Gelatin was used as a specific proteolytic substrate to screen for clostridial protease activity that might contribute to intestinal host matrix degradation. A high variability of gelatinolytic activity was seen. The mean gelatin breakdown by strains from bovine enterotoxemia was not different from other strains, independent of the origin (Figure 1D). No significant difference between the groups could be observed.
Enterotoxemia strains have no increased intra-species growth-inhibitory activity
The intra-species growth-inhibitory activity is shown in Figure 2. Of all tested strains, sixty-one percent was able to inhibit growth of at least one other C. perfringens strain. There was a lot of variation between the inhibitory spectra of the tested strains. Some strains inhibited only a limited number of strains, while others had a broad inhibitory spectrum. Five out of eight enterotoxemia strains, eight out of twenty-three strains from healthy calves, four out of five ruminating bovine strains and one out of five sheep strains were unable to inhibit growth of any other strain. No significant differences between the groups could be observed.
Clostridium perfringens type A strains isolated from bovine enterotoxemia cases showed no difference in in vitro expression of a selection of potential virulence factors compared to strains from healthy cattle as well as various other animal species. This is in accordance with the capacity of lesion induction in a calf intestinal loop model, in which all tested strains are capable of inducing necro-hemorrhagic intestinal lesions, independent of the origin of the isolate .
No increased activity of the alpha toxin and perfringolysin O was detected in bovine enterotoxemia strains. In a recent study carried out with alpha toxin and perfringolysin O mutants we demonstrated an essential role of both toxins in bovine enterotoxemia . The alpha toxin is the most toxic enzyme produced by C. perfringens type A strains and hydrolyses two major constituents of the eukaryotic membrane (phosphatidylcholine and sphingomyelin) causing membrane disruption and cell lysis [11, 12]. In sublytic concentrations, alpha toxin leads to activation of signal transduction pathways and uncontrolled production of intracellular mediators [12–14]. Perfringolysin O is a pore-forming cytolysin which has the ability to kill eukaryotic cells by punching holes in their membranes . As shown in vitro and in a calf intestinal loop model, alpha toxin and perfringolysin O seem to have a synergistic action in bovine enterotoxemia . Considering this essential role of alpha toxin and perfringolysin O in bovine enterotoxemia, C. perfringens type A strains with higher activity of these toxins might be more virulent. Despite the importance of alpha toxin and perfringolysin O in enterotoxemia, strains originating from diseased animals showed no higher activities of these toxins in vitro.
No increased collagen degrading and mucinolytic potential was detected in strains from enterotoxemia cases. Collagen is widely distributed throughout the body and is an integral component of the connective tissue. Collagen disruption by bacterial collagenases may result in the loss of tissue integrity and subsequent tissue necrosis in the infected host and allow penetration of bacterial toxins to deeper tissues . Therefore, the ability to produce collagenase may play an important role in the tissue destruction observed in bovine enterotoxemia. This in vitro study showed no difference in collagen destroying potential between C. perfringens strains from bovine enterotoxemia cases compared to strains from healthy cattle, sheep and chickens.
In addition to the collagen degradation, the mucinolytic activity of the C. perfringens strains may also contribute to the pathology of bovine enterotoxemia. The gastrointestinal tract represents a large surface of the host that interacts with the external world. A protective mucus layer covers the epithelial surface, forming a barrier between the lumen and the intestinal epithelium. It is a potential binding site for both commensal and pathogenic organisms [17, 18]. C. perfringens type A strains with stronger mucinolytic activity may have an advantage in colonizing and degrading the protective mucus layer, which may lead to a compromised barrier function. Enterotoxemia strains, however were not different from the other strains with respect to their mucinolytic activity in vitro.
Another possible virulence trait that was explored is the ability to cause intra-species growth-inhibition. The potential of a pathogenic strain to suppress the growth of other C. perfringens strains has been shown in necrotic enteritis in broiler chickens, leading to single clone dominance in a broiler flock suffering from necrotic enteritis [9, 19]. In contrast to the situation in broiler chickens, our results showed no difference in intra-species growth-inhibition between the enterotoxemia strains and other C. perfringens strains. In addition, a clonal population of C. perfringens does not seem to be essential for the development of bovine enterotoxemia as seen by RAPD (authors unpublished observations). Together this suggests that intra-species growth-inhibition probably does not play a role in the pathogenesis of bovine enterotoxemia.
None of the possible virulence traits examined in this study were distinctive for C. perfringens type A strains isolated from bovine enterotoxemia cases in vitro. This is in accordance with a recent observation from our laboratory that, when the conditions are favorable, strains from different origin are capable to provoke necro-hemorrhagic lesions in an intestinal loop model . It cannot be ruled out that other possible virulence factors may be involved in disease. This was the case for necrotic enteritis in broiler chickens, an enteric disease caused by C. perfringens type A strains. The essential virulence factor for causing disease remained unclear until the NetB toxin, a previously unknown toxin specific for necrotic enteritis, was found . Although the presence of such an undiscovered toxin in the pathology of bovine enterotoxemia cannot be excluded, it is unlikely because type A strains originating from bovine enterotoxemia cases as well as from healthy cattle and other animal species are capable of inducing lesions in an intestinal loop model .
Strains from bovine enterotoxemia cases did not have a higher alpha toxin, perfringolysin O, mucinolytic or gelatinolytic activity in comparison to strains isolated from healthy cattle and other animal species. Also production of intra-species inhibitory substances was not higher in bovine enterotoxemia strains. This could indicate that yet another, hitherto unknown, C. perfringens virulence factor might be involved in the pathogenesis of calf enterotoxemia. Taking these results together with our previous observations that strains from various origin can induce the typical lesions in an intestinal loop model , it seems however more plausible that the primary trigger in bovine enterotoxemia is not C. perfringens and that C. perfringens is merely responsible for propagating and exacerbating the intestinal damage to the point that it becomes hemorrhagic and necrotic.
Bacterial strains and culture conditions
The 46 C. perfringens strains used in this study are listed in Table 1. One isolate per animal was used. Eight strains were isolated from enterotoxemic calves and 23 from healthy calves. Also five strains from ruminating cattle were included. In addition five strains isolated from chicken and five ovine strains were included. This study describes the in vitro characterization of Clostridium perfringens strains and thus does not need approval of an ethical committee.
Bacteria were isolated on Columbia agar (Oxoid, Basingstoke, UK) supplemented with 5% defibrinated sheep blood, 12 mg/l kanamycin sulphate and 30 000 IU/l polymixin B sulphate. The toxinotype of the C. perfringens strains was determined by a multiplex polymerase chain reaction (PCR), as described by Yoo et al. , while the presence of the enterotoxin, NetB and the consensus and atypical beta2 toxin genes were detected with previously described single PCR reactions [20, 24, 25]. The strains were cultured anaerobically for 24 h at 37°C in TGY broth (3% tryptone, 2% yeast extract, 0.1% glucose and 0.1% L-cysteine) for the toxin assays, in BHI broth (VWR, Leuven, Belgium) supplemented with 0.4% (w/v) glucose for growth-inhibition assays and measurements of gelatinolytic activity and in tryptone soy broth (TSB) (Oxoid) for quantification of the mucinolytic activity. Cell-free supernatants from the C. perfringens cultures were obtained by centrifugation followed by filtration of the supernatants through a 0.2 μm filter and stored at −20°C.
Detection of toxin activity
To determine the alpha toxin activity in the supernatants, the lecithinase acitivity was assayed in an egg yolk agar well diffusion assay . Therefore 7 mm diameter holes were punched out in Columbia agar (Oxoid) supplemented with 2% (vol/vol) egg yolk with the back of a 20-200 μl pipette tip and 20 μl of the tested supernatants was added to each hole. Pure alpha toxin (Sigma-Aldrich, St-Louis, USA) was used as standard. Plates were incubated at 37°C for 24 hours and scanned with a GS-800 calibrated densitometer (Bio-Rad Laboratories, Hercules, CA). The diameters of the zones of opacity were measured using Quantity One software (Bio-Rad Laboratories).
Perfringolysin O (PFO) activity in the supernatants was determined by measuring the hemolysis of horse erythrocytes using a doubling dilution assay as previously described . The PFO titer is the reciprocal of the last dilution which showed complete hemolysis. The unit of activity was expressed on a logarithmic scale as a log2 value (titer), and consequently each difference in titer of one unit represents a twofold difference in perfringolysin O activity.
Both assays were performed in triplicate, with supernatants of two independent biological replicates of C. perfringens cultures grown in TGY.
Detection and measurement of proteolytic activity
To determine the mucinolytic activity of the different C. perfringens strains, 7 mm diameter holes were punched out TSA plates supplemented with 0.5% (w/v) type II gastric mucin (Sigma-Aldrich) with the back of a 20-200 μl pipette tip. Twenty μl of each overnight culture was added to each hole (3 wells per overnight culture). The plates were anaerobically incubated for 16 hours at 37°C and subsequently stained for 30 minutes with amido black staining solution (Sigma-Aldrich). Plates were destained with destaining solution (25% isopropanol and 10% acetic acid) and scanned with a GS-800 calibrated densitometer (Bio-Rad Laboratories). Lysis of mucin was observed as a halo of clearing around the wells. The diameters of the zones of mucin lysis were measured using Quantity One software (Bio-Rad Laboratories).
Detection of gelatinolytic activity with an EnzChek Gelatinase/Collagenase Assay kit was carried out according to the recommendations of the manufacturer (Molecular Probes). Briefly, filter-sterilized supernatant of BHI overnight cultures was incubated with 12.5 μg/ml fluorescein-labeled gelatin substrate for 3 hours at 37°C (2 wells per overnight culture). Gelatinolytic activity was measured as an increase in fluorescence (excitation 495 nm, emission 515 nm) by a Fluoroskan Ascent Fluorometer and Luminometer (Thermo Fisher Scientific Inc., Waltham, USA). Both assays were performed with two independent biological replicates of C. perfringens cultures.
In vitrogrowth-inhibition assay
All 46 C. perfringens strains were used in a checkerboard test for intra-species growth-inhibition as previously described . Each strain was cultured anaerobically in BHI broth for 24 h at 37°C. The overnight cultures were diluted 1/1000 in 10 ml BHI agar and poured on the whole surface of BHI agar plates to obtain a bacterial lawn. With a sterile toothpick each C. perfringens isolate was transferred from the overnight culture to the agar plates seeded with the different C. perfringens strains. Absence of growth of the bacterial lawn around a colony results in an inhibition zone. After overnight incubation under anaerobic conditions, inhibition was evaluated. The test was performed in duplicate.
All tests were performed in duplicate and data were analyzed using a Kruskal-Wallis test followed by a Dunn’s multiple comparison test. Statistical analyses were performed using GraphPad Prism 5 software.
Muylaert A, Lebrun M, Duprez JN, Labrozzo S, Theys H, Taminiau B, Mainil J: Enterotoxaemia-like syndrome and Clostridium perfringens in veal calves. Vet Rec. 2010, 167 (2): 64-65. 10.1136/vr.b4869.
Lebrun M, Mainil JG, Linden A: Cattle enterotoxaemia and Clostridium perfringens: description, diagnosis and prophylaxis. Vet Rec. 2010, 167 (1): 13-22. 10.1136/vr.167.1.12.
Pardon B, De Bleecker K, Hostens M, Callens J, Dewulf J, Deprez P: Longitudinal study on morbidity and mortality in white veal calves in Belgium. BMC Vet Res. 2012, 8: 26-10.1186/1746-6148-8-26.
Matches JR, Liston J, Curran D: Clostridium perfringens in the environment. Appl Microbiol. 1974, 28 (4): 655-660.
Manteca C, Daube G, Pirson V, Limbourg B, Kaeckenbeeck A, Mainil JG: Bacterial intestinal flora associated with enterotoxaemia in Belgian Blue calves. Vet Microbiol. 2001, 81 (1): 21-32. 10.1016/S0378-1135(01)00329-7.
Songer JG: Clostridial enteric diseases of domestic animals. Clin Microbiol Rev. 1996, 9 (2): 216-234.
Rood JI: Virulence genes of Clostridium perfringens. Annu Rev Microbiol. 1998, 52: 333-360. 10.1146/annurev.micro.52.1.333.
Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Vermeulen K, Schauvliege S, Haesebrouck F, Ducatelle R, Deprez P, et al: The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells. Vet Res. 2013, 44 (1): 45-10.1186/1297-9716-44-45.
Timbermont L, Lanckriet A, Pasmans F, Haesebrouck F, Ducatelle R, Van Immerseel F: Intra-species growth-inhibition by Clostridium perfringens is a possible virulence trait in necrotic enteritis in broilers. Vet Microbiol. 2009, 137 (3–4): 388-391.
Valgaeren B, Pardon B, Goossens E, Verherstraeten S, Schauvliege S, Timbermont L, Ducatelle R, Deprez P, Van Immerseel F: Lesion development in a new intestinal loop model indicates the involvement of a shared clostridium perfringens virulence factor in haemorrhagic enteritis in calves. J Comp Pathol. 2013, 149: 103-112. 10.1016/j.jcpa.2012.11.237.
Awad MM, Bryant AE, Stevens DL, Rood JI: Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Microbiol Biotechnol. 1995, 15 (2): 191-202.
Titball RW: Bacterial phospholipases C. Microbiol Rev. 1993, 57 (2): 347-366.
Sakurai J, Nagahama M, Oda M: Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem. 2004, 136 (5): 569-574. 10.1093/jb/mvh161.
Titball RW, Naylor CE, Basak AK: The Clostridium perfringens alpha-toxin. Anaerobe. 1999, 5 (2): 51-64. 10.1006/anae.1999.0191.
Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW: Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell. 1997, 89 (5): 685-692. 10.1016/S0092-8674(00)80251-2.
Harrington DJ: Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease. Infect Immun. 1996, 64 (6): 1885-1891.
Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M: Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut. 2000, 47 (4): 589-594. 10.1136/gut.47.4.589.
Chang M, Alsaigh T, Kistler EB, Schmid-Schonbein GW: Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS One. 2012, 7 (6): e40087-10.1371/journal.pone.0040087.
Gholamiandekhordi AR, Ducatelle R, Heyndrickx M, Haesebrouck F, Van Immerseel F: Molecular and phenotypical characterization of Clostridium perfringens isolates from poultry flocks with different disease status. Vet Microbiol. 2006, 113 (1–2): 143-152.
Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker D, Di Rubbo A, Rood JI, Moore RJ: NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 2008, 4 (2): e26-10.1371/journal.ppat.0040026.
Van Immerseel F, Pardon B, Maes S, Heyndrickx M, Timbermont L, Boyen F, Haesebrouck F, Ducatelle R, Deprez P: Isolation of a clonal population of Clostridium perfringens type A from a Belgian Blue calf with abomasal ulceration. J Comp Pathol. 2010, 143 (4): 289-293. 10.1016/j.jcpa.2010.02.004.
Keyburn AL, Sheedy SA, Ford ME, Williamson MM, Awad MM, Rood JI, Moore RJ: Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun. 2006, 74 (11): 6496-6500. 10.1128/IAI.00806-06.
Yoo HS, Lee SU, Park KY, Park YH: Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR. J Clin Microbiol. 1997, 35 (1): 228-232.
Jost BH, Billington SJ, Trinh HT, Bueschel DM, Songer JG: Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin. Infect Immun. 2005, 73 (1): 652-656. 10.1128/IAI.73.1.652-656.2005.
Meer RR, Songer JG: Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens. Am J Vet Res. 1997, 58 (7): 702-705.
Rigby GJ: An egg-yolk agar diffusion assay for monitoring phospholipase C in cultures of Clostridium welchii. J Appl Bacteriol. 1981, 50 (1): 11-19. 10.1111/j.1365-2672.1981.tb00866.x.
The authors thank A.L. Keyburn for providing the chicken strain NE18 used in this study. This work was supported by the Institute for Science and Technology, Flanders under contract number 090910.
The authors declare that they have no competing interests.
EG, SV, LT, BV, BP, RD, PD and FVI participated in the design of the study. EG, performed the experiments and analyzed the data. BV collected the majority of C. perfringens strains. FH, PD, RD and FVI supervised the study. EG, FH, RD, PD and FVI wrote the paper. All authors contributed to the critical revision of the manuscript for important intellectual content and have seen and approved the final draft. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( https://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Goossens, E., Verherstraeten, S., Timbermont, L. et al. Clostridium perfringens strains from bovine enterotoxemia cases are not superior in in vitroproduction of alpha toxin, perfringolysin O and proteolytic enzymes. BMC Vet Res 10, 32 (2014). https://doi.org/10.1186/1746-6148-10-32
- Broiler Chicken
- Clostridium Perfringens
- Gelatinolytic Activity
- Sudden Death Syndrome
- Alpha Toxin